Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

7,975 public trials 742 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry

NCT01498653

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Guangzhou, Guangdong, China
  • GSK Investigational Site Changsha, Hunan, China
  • GSK Investigational Site Shenyang, Liaoning, China
  • GSK Investigational Site Shenyang, Liaoning, China
View all 24 locations
View Trial Details
Completed

Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents

NCT01431950

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Long Beach, California, United States
  • GSK Investigational Site Newport Beach, California, United States
  • GSK Investigational Site Colorado Springs, Colorado, United States
  • GSK Investigational Site Clearwater, Florida, United States
View all 40 locations
View Trial Details
Completed

Cross-Over Study in Subjects With COPD, Evaluating Lung Function Response After Treatment With Once Daily Umeclidinium 62.5mcg, Vilanterol 25mcg, and Umeclidinium/Vilanterol 62.5/25mcg

NCT01716520

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Haapsalu, Estonia
  • GSK Investigational Site Tallinn, Estonia
  • GSK Investigational Site Tallinn, Estonia
  • GSK Investigational Site Tallinn, Estonia
View all 21 locations
View Trial Details
Completed

A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT00363896

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Almirall Investigational Sites#947 Les Escaldes, Andorra
  • Almirall Investigational Sites#645 Graz, Austria
  • Almirall Investigational Sites#646 Innsbruck, Austria
  • Almirall Investigational Sites#644 Linz, Austria
View all 132 locations
View Trial Details
Completed

To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways

NCT02085161

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site San Diego, California, United States
  • Boehringer Ingelheim Investigational Site Torrance, California, United States
  • Boehringer Ingelheim Investigational Site Hartford, Connecticut, United States
  • Boehringer Ingelheim Investigational Site Daw Park, South Australia, Australia
View all 34 locations
View Trial Details
Completed

Long-term Extension Study of the Safety, Tolerability, and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-36)

NCT00970268

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations
  • Forest Investigative Site 1162 Birmingham, Alabama, United States
  • Forest Investigative Site 1127 Mobile, Alabama, United States
  • Forest Investigative Site 0909 Glendale, Arizona, United States
  • Forest Investigative Site 2060 Phoenix, Arizona, United States
View all 83 locations
View Trial Details
Completed

A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT00500318

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +16 more
Locations
  • Forest Investigative Site 2088 Jasper, Alabama, United States
  • Forest Investigative Site 0909 Phoenix, Arizona, United States
  • Forest Investigative Site 0957 Long Beach, California, United States
  • Forest Investigative Site 0973 Los Angeles, California, United States
View all 52 locations
View Trial Details
Completed

Efficacy and Safety of Aclidinium Bromide for Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-33)

NCT00891462

Conditions
Bronchial Diseases, Bronchitis, Bronchitis, Chronic, +12 more
Locations
  • Forest Investigative Site Birmingham, Alabama, United States
  • Forest Investigative Site Jasper, Alabama, United States
  • Forest Investigative Site Mobile, Alabama, United States
  • Forest Investigative Site Mesa, Arizona, United States
View all 112 locations
View Trial Details

Related conditions